Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
August 31, 2023
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
September 27, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
October 3, 2023
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
June 12, 2023
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
May 22, 2023
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
April 26, 2023
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
April 17, 2023
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
February 21, 2023
Quantum Motion Raises £42 Million Investment Round
All News
06•01•23
Portfolio News
Perspectum
Perspectum completes $36 million first close of series C funding led by Oppenheimer Holding
21•05•22
Portfolio News
Perspectum
FDA grants clearance to Perspectum's CoverScan - A new platform-based tool to assess multiple organs in one MRI scan
27•01•22
Portfolio News
Perspectum
Perspectum announces first patient recruited for multi-year collaborative primary sclerosing cholangitis (PSC) pediatric study
08•07•21
Portfolio News
Perspectum
Perspectum launches new clinical study to investigate integrated diagnostics to enable precision medicine for liver cancer patients
03•05•21
Portfolio News
Perspectum
Perspectum partners in a new study in Singapore for the early detection of liver cancer using precision medicine
25•04•21
Portfolio News
Perspectum
Perspectum study shows measurable organ impairment in long COVID patients
28•03•21
Portfolio News
Perspectum
Perspectum research links high liver fat to increased risk of hospitalization in COVID-19 patients with obesity
01•03•21
Portfolio News
Perspectum
Perspectum lands top spot in Alantra Pharma Fast 50 rankings
15•01•21
Portfolio News
Perspectum
Perspectum’s CoverScan MD approved by the UK’s MHRA – the world’s first integrated imaging service capable of mapping the impact of COVID-19 on the body
05•01•21
Portfolio News
Perspectum
Perspectum issued CPT Codes for LiverMultiScan by the American Medical Association to help clinicians diagnose and treat liver disease
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal